Background Intermittent preventive treatment (IPT) is a promising strategy for malaria
control in infants. We undertook a pooled analysis of the safety and efficacy of IPT in infants (IPTi) …

Clinical trials from the 1970s and 1980s have shown the efficacy, safety, and practicability of
the treatment of Plasmodium falciparum malaria with clindamycin. Two reviews from the …

… Bertrand Lell helped with fieldwork and clinical aspects of the study. Andre Deelder
advised on parasitological aspects of the study and helped to supervise some immunological …

Background The replication-competent recombinant vesicular stomatitis virus (rVSV)–based
vaccine expressing a Zaire ebolavirus (ZEBOV) glycoprotein was selected for rapid safety …

Background The RTS,S/AS01 vaccine targets the circumsporozoite protein of Plasmodium
falciparum and has partial protective efficacy against clinical and severe malaria disease in …

Background Increasing drug resistance limits the choice of efficacious chemotherapy
against Plasmodium falciparum malaria in Africa. Amodiaquine still retains efficacy against P …

Background The RTS,S/AS01 malaria vaccine targets the circumsporozoite protein,
inducing antibodies associated with the prevention of Plasmodium falciparum infection. We …

Coronavirus disease 2019 (COVID-19) has spread rapidly and extensively to most countries
in the world, resulting in considerable mortality in Europe and the United States, as well as …

We compared interleukin-12 (IL-12) and other cytokine activities during and after an acute
clinical episode in a matched-pair case-control study of young African children who presented …

… The (T1B) 4 molecule, a multiple-antigen peptide based on a tetramer of conserved T and
B cell epitopes of the circumsporozoite protein, has proven immunostimulatory capacity and …